---
title: "MindWalk Holdings (HYFT) news: offering and buyback"
url: "https://aibio.space/companies/mindwalk/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "HYFT offering and buyback news: MindWalk added to Russell 3000E Index, then files $250,000,000 shelf. MindWalk Holdings Corp. (NASDAQ: HYFT), United States."
---

HYFT MindWalk Holdings Corp. NASDAQ · United States

# MindWalk Holdings (HYFT) news HYFT offering and buyback news

Debt Financing · 2026-09-14

## [MindWalk signs binding $30 million credit facility term sheet](https://aibio.space/news/mindwalk-signs-binding-30-million-credit-facility-term-sheet/)

MindWalk Holdings signed a binding term sheet with Sanabil (Cayman) for a revolving credit facility of up to $30 million at a fixed 7.00% annual rate. The definitive agreement is not yet signed.

## Latest MindWalk Holdings news

1. 2026-07-06 Financings [MindWalk added to Russell 3000E Index, then files $250,000,000 shelf](https://aibio.space/news/mindwalk-added-russell-3000e-index-then-files-250-000-000-shelf/) The index change took effect after the U.S. market close on June 26, 2026. A Form F-3 filed on July 13, 2026 replaces an older shelf and includes a $50,000,000 at-the-market program.
2. 2025-10-09 Financings [MindWalk authorizes buyback of up to 2.3 million shares](https://aibio.space/news/mindwalk-authorizes-buyback-up-2-3-million-shares/) The twelve-month program starts October 15, 2025. The company says it represents approximately 5% of the 46,154,188 common shares outstanding.
3. 2025-07-29 Listings [ImmunoPrecise Antibodies (now MindWalk Holdings) reports fiscal 2025 results](https://aibio.space/news/immunoprecise-antibodies-now-mindwalk-holdings-reports-fiscal-2025/) Revenue was $24.5 million in both fiscal 2025 and fiscal 2024, and the net loss widened to $30.2 million from $26.1 million. The release gives no date for the regained Nasdaq compliance.

## MindWalk Holdings at a glance

- **Ticker**: HYFT

- **Listing**: NASDAQ

- **Country**: United States

### Related companies

- [BANGI INC](https://aibio.space/companies/bangi/) OTC: BNGI
- [Filana Therapeutics](https://aibio.space/companies/filana-therapeutics/) NASDAQ: FLNA
- [Bio-Path Holdings](https://aibio.space/companies/bio-path/) OTC: BPTH
- [Verastem](https://aibio.space/companies/verastem/) NASDAQ: VSTM
- [Adaptive Biotechnologies](https://aibio.space/companies/adaptive-biotechnologies/) NASDAQ: ADPT
- [Decoy Therapeutics](https://aibio.space/companies/decoy-therapeutics/) NASDAQ: DCOY
- [Foghorn Therapeutics](https://aibio.space/companies/foghorn-therapeutics/) NASDAQ: FHTX
- [INmune Bio](https://aibio.space/companies/inmune-bio/) NASDAQ: INMB

### Also on NASDAQ

- [Kyverna Therapeutics](https://aibio.space/companies/kyverna-therapeutics/) KYTX
- [InMode](https://aibio.space/companies/inmode/) INMD
- [Contineum Therapeutics](https://aibio.space/companies/contineum-therapeutics/) CTNM
- [Tyra Biosciences](https://aibio.space/companies/tyra-biosciences/) TYRA
- [COOPER COMPANIES, INC.](https://aibio.space/companies/cooper-companies/) COO
- [ADMA Biologics](https://aibio.space/companies/adma-biologics/) ADMA

## Questions about MindWalk Holdings

Has MindWalk Holdings raised money recently?

Our latest story on this, dated Jul 6, 2026: "MindWalk added to Russell 3000E Index, then files $250,000,000 shelf". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/mindwalk-added-russell-3000e-index-then-files-250-000-000-shelf/).

Does MindWalk Holdings have a share buyback?

Our latest story on this, dated Oct 9, 2025: "MindWalk authorizes buyback of up to 2.3 million shares". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/mindwalk-authorizes-buyback-up-2-3-million-shares/).

What is the ticker symbol of MindWalk Holdings?

MindWalk Holdings Corp. trades under the ticker HYFT on NASDAQ.

Where is MindWalk Holdings listed?

MindWalk Holdings Corp. is listed on NASDAQ. Our directory also records these other listings: GETTEX:TQB0; LSX:A41GYL.

What is the SEC CIK of MindWalk Holdings?

The SEC Central Index Key (CIK) for MindWalk Holdings Corp. is 1715925. Its filings are on SEC EDGAR.

How many shares does MindWalk Holdings have outstanding?

46,711,866 shares as of 2026-04-30, per the cover page of its 20-F filed 2026-07-23.

Which country or territory is MindWalk Holdings listed under?

Our directory records MindWalk Holdings Corp. under United States.

What does MindWalk Holdings do?

Our directory classifies MindWalk Holdings Corp. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of MindWalk Holdings?

The ISIN recorded for MindWalk Holdings Corp. is CA6026871054.

Does aibio.space cover MindWalk Holdings?

aibio.space lists MindWalk Holdings Corp. among 2,820 public biotech companies and publishes its news here as stories appear.

Where is MindWalk Holdings incorporated?

SEC records list its state or country of incorporation as A1.

What is the latest MindWalk Holdings (HYFT) stock news?

Our latest story on MindWalk Holdings, dated Sep 14, 2026: "MindWalk signs binding $30 million credit facility term sheet". MindWalk Holdings signed a binding term sheet with Sanabil (Cayman) for a revolving credit facility of up to $30 million at a fixed 7.00% annual rate. The definitive agreement is not yet signed. [Source](https://aibio.space/news/mindwalk-signs-binding-30-million-credit-facility-term-sheet/).

Does MindWalk Holdings have debt, a term loan or convertible notes?

Our latest debt story, dated Sep 14, 2026: "MindWalk signs binding $30 million credit facility term sheet". MindWalk Holdings signed a binding term sheet with Sanabil (Cayman) for a revolving credit facility of up to $30 million at a fixed 7.00% annual rate. The definitive agreement is not yet signed. [Source](https://aibio.space/news/mindwalk-signs-binding-30-million-credit-facility-term-sheet/).

How long will MindWalk Holdings's cash last?

From our story of Jul 6, 2026: It also lists going-concern risk and the risk that the company may fail to remediate a material weakness. [Source](https://aibio.space/news/mindwalk-added-russell-3000e-index-then-files-250-000-000-shelf/).

Is MindWalk Holdings at risk of delisting?

Our latest listing story, dated Jul 29, 2025: "ImmunoPrecise Antibodies (now MindWalk Holdings) reports fiscal 2025 results". Revenue was $24.5 million in both fiscal 2025 and fiscal 2024, and the net loss widened to $30.2 million from $26.1 million. The release gives no date for the regained Nasdaq compliance. [Source](https://aibio.space/news/immunoprecise-antibodies-now-mindwalk-holdings-reports-fiscal-2025/).

## Investor discussion: MindWalk Holdings

Members talk about MindWalk Holdings (HYFT). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at MindWalk Holdings, newest first. Each line links the filing it comes from.

1. 2026-07-23 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 20-F. [Source](https://www.sec.gov/Archives/edgar/data/1715925/000119312526312694/hyft-20260430.htm)
2. 2026-07-22 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1715925/000119312526312521/hyft-ex99_1.htm)
3. 2026-07-06 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1715925/000119312526295719/hyft-ex99_1.htm)
4. 2025-11-07 Financings Reported a financing. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/1715925/000106299325016561/form424b5.htm)
5. 2025-10-09 Financings Announced a share repurchase program. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1715925/000119312525235316/hyft-ex99_1.htm)
6. 2025-07-29 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1715925/000095017025099401/ipa-ex99_1.htm)
7. 2025-07-14 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1715925/000095017025095473/ipa-ex99_1.htm)
8. 2025-03-28 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1715925/000095017025046380/ipa-ex99_1.htm)
9. 2025-01-27 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1715925/000095017025009017/ipa-ex99_1.htm)

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:HYFT on TradingView](https://www.tradingview.com/symbols/NASDAQ-HYFT/).

## SEC filings and registration

- **SEC name**: MindWalk Holdings Corp.

- **CIK**: 1715925

- **Industry (SIC)**: Pharmaceutical Preparations (2834)

- **US tickers**: HYFT (Nasdaq)

- **State or country of incorporation**: A1

- **Fiscal year ends**: April 30

- **Filer category**: Non-accelerated filer

- **Business address**: 3204-4464 MARKHAM STREET, VICTORIA

- **Phone**: 6048060626

- **Shares outstanding**: 46,711,866 as of 2026-04-30 (20-F filed 2026-07-23)

- **Former names**: ImmunoPrecise Antibodies Ltd.

### Recent filings (8-K and 6-K are the company's own announcements)

- [6-K](https://www.sec.gov/Archives/edgar/data/1715925/000119312526429101/press_release_oct_22_202.htm) filed 2026-10-22
- [6-K](https://www.sec.gov/Archives/edgar/data/1715925/000119312526427256/press_release_oct_21_202.htm) filed 2026-10-21
- [6-K](https://www.sec.gov/Archives/edgar/data/1715925/000119312526421155/press_release_oct_14_202.htm) filed 2026-10-14
- [6-K](https://www.sec.gov/Archives/edgar/data/1715925/000119312526415053/press_release_oct_6_2026.htm) filed 2026-10-06
- [6-K](https://www.sec.gov/Archives/edgar/data/1715925/000119312526410650/d34138d6k.htm) filed 2026-10-01
- [6-K](https://www.sec.gov/Archives/edgar/data/1715925/000119312526396682/nomrd_fy27.htm) filed 2026-09-21
- [6-K](https://www.sec.gov/Archives/edgar/data/1715925/000119312526396193/press_release_sep_21_202.htm) filed 2026-09-21
- [6-K](https://www.sec.gov/Archives/edgar/data/1715925/000119312526390719/earnings_release_sep_14_.htm) filed 2026-09-14

Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001715925), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices.

## Listing details

MindWalk Holdings Corp. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker HYFT, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: MindWalk Holdings Corp.

- **Ticker**: HYFT

- **Listing**: NASDAQ

- **Country or territory**: United States

- **Business scope**: Biotechnology

- **ISIN**: CA6026871054

- **Other listed symbols**: GETTEX:TQB0; LSX:A41GYL

- **Last quote in directory**: 2026-10-21

- **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-HYFT/)

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/mindwalk/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "MindWalk Holdings (HYFT) news: offering and buyback", 2026-10-31, https://aibio.space/companies/mindwalk/